We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$778M
AUM Growth
-$1.85M
Cap. Flow
-$35.3M
Cap. Flow %
-4.54%
Top 10 Hldgs %
34.42%
Holding
5,522
New
919
Increased
1,531
Reduced
1,579
Closed
1,330

Sector Composition

Rank Sector Weight
1 Industrials 6%
2 Financials 5.45%
3 Technology 5.24%
4 Consumer Discretionary 4.75%
5 Healthcare 3.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QURE icon
2726
uniQure
QURE
$3.15B
$6K ﹤0.01%
431
+430
+43,000% +$4.68K
QYLD icon
2727
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.24B
$6K ﹤0.01%
230
+100
+77% +$2.5K
RHI icon
2728
Robert Half
RHI
$4.16B
$6K ﹤0.01%
134
-1,566
-92% -$70.1K
RM icon
2729
Regional Management Corp
RM
$305M
$6K ﹤0.01%
392
-241
-38% -$4.14K
RRC icon
2730
Range Resources
RRC
$9.01B
$6K ﹤0.01%
71
-1,764
-96% -$158K
SJT
2731
San Juan Basin Royalty Trust
SJT
$115M
$6K ﹤0.01%
300
-4,473
-94% -$84K
SNOA icon
2732
Sonoma Pharmaceuticals
SNOA
$5.98M
$6K ﹤0.01%
2
-24
-92% -$71K
SONY icon
2733
Sony
SONY
$136B
$6K ﹤0.01%
1,755
-12,400
-88% -$42.8K
SWX icon
2734
Southwest Gas
SWX
$6.69B
$6K ﹤0.01%
108
-503
-82% -$26.7K
SXC icon
2735
SunCoke Energy
SXC
$815M
$6K ﹤0.01%
+300
New +$6.3K
TBPH icon
2736
Theravance Biopharma
TBPH
$877M
$6K ﹤0.01%
+174
New +$5.24K
TEI
2737
Templeton Emerging Markets Income Fund
TEI
$318M
$6K ﹤0.01%
428
-3,214
-88% -$45.6K
TLF icon
2738
Tandy Leather Factory
TLF
$19.9M
$6K ﹤0.01%
591
-145
-20% -$1.37K
TNDM icon
2739
Tandem Diabetes Care
TNDM
$1.29B
$6K ﹤0.01%
+39
New +$6.64K
UBT icon
2740
ProShares Ultra 20+ Year Treasury
UBT
$57.3M
$6K ﹤0.01%
200
-200
-50% -$6.19K
UEC icon
2741
Uranium Energy
UEC
$5.32B
$6K ﹤0.01%
4,112
-15,211
-79% -$21.5K
VAC icon
2742
Marriott Vacations Worldwide
VAC
$4.28B
$6K ﹤0.01%
+110
New +$6.16K
VTOL icon
2743
Bristow Group
VTOL
$1.33B
$6K ﹤0.01%
+98
New +$5.7K
WWW icon
2744
Wolverine World Wide
WWW
$1.56B
$6K ﹤0.01%
246
-342
-58% -$9.1K
PAMT
2745
PAMT Corp
PAMT
$315M
$6K ﹤0.01%
888
-116
-12% -$702
EVBN
2746
DELISTED
Evans Bancorp Inc
EVBN
$6K ﹤0.01%
271
-892
-77% -$20.4K
INFN
2747
DELISTED
Infinera Corporation Common Stock
INFN
$6K ﹤0.01%
634
+334
+111% +$2.97K
HYB
2748
DELISTED
New America High Income Fund, Inc.
HYB
$6K ﹤0.01%
612
-130
-18% -$1.29K
BIOL
2749
DELISTED
Biolase, Inc.
BIOL
0
PXD
2750
DELISTED
Pioneer Natural Resource Co.
PXD
$6K ﹤0.01%
24
-480
-95% -$99.1K

Similar funds

Tower Research Capital (TRC)'s Q2 2014 Portfolio in Review

As of Q2 2014, Tower Research Capital (TRC) held 5,522 positions worth $778M, down 0.24% from $780M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $35.3M in Q2 2014, closing 1,330 positions and reducing 1,579 holdings. Its most notable exit was iShares Core S&P Small-Cap ETF, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 6% of assets, up from 5.1% a quarter earlier, followed by Financials and Technology.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $9.03M.

  • Tower Research Capital (TRC)'s largest Q2 2014 buy was iShares Russell 1000 Value ETF: 89,185 shares worth $9.03M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2014, an estimated $177M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2014 reduction was Invesco QQQ Trust, cutting an estimated $110M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Small-Cap ETF in Q2 2014, selling an estimated $10.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $778M portfolio in Q2 2014.
  • Tower Research Capital (TRC) opened 919 new positions and closed 1,330 in Q2 2014.
  • Tower Research Capital (TRC)'s portfolio value fell 0.24% quarter-over-quarter to $778M.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2014, filed 14 Aug 2014.